Johan E. Palm
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 9
-
- Pharmacological Effects and Toxicity Studies 4
- Pharmaceutical studies and practices 2
- Co-authors
- Per Artursson (3 shared papers)Christel A. S. Bergström (4 shared papers)Kim L. R. Brouwer (1 shared paper)Yurong Lai (1 shared paper)Yaofeng Cheng (1 shared paper)Dietrich O. R. KEPPLER (1 shared paper)Keith A. Hoffmaster (1 shared paper)Raymond Evers (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Molecular Pharmaceutics (2 papers)Pharmaceutical Research (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Johan E. Palm
12 papers receiving 440 citations
Peers
Comparison fields: 5 of 59
- Pharmacology 148
- Oncology 349
- Pediatrics, Perinatology and Child Health 186
- Infectious Diseases 56
- Biochemistry 22
Countries citing papers authored by Johan E. Palm
This map shows the geographic impact of Johan E. Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan E. Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan E. Palm more than expected).
Fields of papers citing papers by Johan E. Palm
This network shows the impact of papers produced by Johan E. Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan E. Palm. The network helps show where Johan E. Palm may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan E. Palm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 211 | |
| 2 | 2011 | 107 | |
| 3 | 2013 | 32 | |
| 4 | 2011 | 31 | |
| 5 | 2017 | 31 | |
| 6 | 2013 | 13 | |
| 7 | 2017 | 10 | |
| 8 | 2010 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2017 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2020 | 1 |
About Johan E. Palm
Johan E. Palm is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmaceutical Science, Pharmacology and Infectious Diseases, having authored 12 papers that have together received 455 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug Solubulity and Delivery Systems (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), HIV/AIDS drug development and treatment (2 papers), Pharmaceutical studies and practices (2 papers), Statistical Methods in Clinical Trials (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Pharmacology (148 citations), Oncology (349 citations), Pediatrics, Perinatology and Child Health (186 citations), Infectious Diseases (56 citations) and Biochemistry (22 citations). Johan E. Palm has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Per Artursson, Christel A. S. Bergström, Kim L. R. Brouwer, Yurong Lai, Yaofeng Cheng, Dietrich O. R. KEPPLER, Keith A. Hoffmaster, Raymond Evers, Daniel A.J. Bow and Bruno Stieger. Their work appears in journals such as Drug Metabolism and Disposition, European Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.